Patents by Inventor Steffen Mueller

Steffen Mueller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10180502
    Abstract: A radiometric detector is provided for detecting a measurement variable. The detector is particularly failsafe with, simultaneously, a simple, space-saving and cost-effective design, without having losses in the signal-to-noise ratio.
    Type: Grant
    Filed: January 22, 2018
    Date of Patent: January 15, 2019
    Assignee: Berthold Technologies GmbH & Co. KG
    Inventors: Dirk Moermann, Ewald Freiburger, Steffen Mueller, Tobias Daibenzeiher
  • Publication number: 20190010469
    Abstract: This invention provides an attenuated virus which comprises a modified viral genome containing nucleotide substitutions engineered in multiple locations in the genome, wherein the substitutions introduce synonymous deoptimized codons into the genome. The instant attenuated virus may be used in a vaccine composition for inducing a protective immune response in a subject. The invention also provides a method of synthesizing the instant attenuated virus. Further, this invention further provides a method for preventing a subject from becoming afflicted with a virus-associated disease comprising administering to the subject a prophylactically effective dose of a vaccine composition comprising the instant attenuated virus.
    Type: Application
    Filed: July 16, 2018
    Publication date: January 10, 2019
    Inventors: Eckard Wimmer, Steve Skiena, Steffen Mueller, Bruce Futcher, Dimitris Papamichail, John Robert Coleman, Jeronimo Cello
  • Publication number: 20190002837
    Abstract: This invention provides an attenuated virus comprising a modified viral genome engineered to containing multiple nucleotide substitutions that reduce the codon pair bias of a virus protein encoding sequence relative to a first host while the codon pair bias relative to a second host is not substantially reduced. In another embodiment, the invention provides an attenuated virus comprising modified viral genome engineered to containing multiple nucleotide substitutions that reduce the codon pair bias of a virus protein-encoding sequence relative to a first host and a second host. The attenuated virus may be used in a vaccine composition for inducing a protective immune response in a subject. The invention also provides a method of synthesizing the attenuated virus.
    Type: Application
    Filed: September 8, 2015
    Publication date: January 3, 2019
    Applicant: The Research Foundation for The State University of New York
    Inventors: Eckard Wimmer, Steffen Mueller, Bruce Futcher, Sam Shen, Charles Stauft, Charles Ward
  • Patent number: 10132940
    Abstract: A radiometric measuring device includes a scintillator, at least one semiconductor photodiode, wherein the at least one semiconductor photodiode is optically coupled to the scintillator, a signal evaluation unit which is electrically coupled to the at least one semiconductor photodiode and is designed to determine a measurement variable on the basis of a measurement signal produced by way of the at least one semiconductor photodiode, and an interface. The radiometric measuring device can be coupled to at least one receiver by way of the interface for the purpose of interchanging data. The radiometric measuring device is designed to be supplied with electrical energy solely via the interface thereof.
    Type: Grant
    Filed: May 20, 2016
    Date of Patent: November 20, 2018
    Assignee: Berthold Technologies GmbH & Co. KG
    Inventors: Steffen Mueller, Ewald Freiburger, Tobias Daibenzeiher
  • Patent number: 10047096
    Abstract: The present application relates to novel (3-hydroxyphenyl)amino-substituted pyrido[2,3-b][1,5]benzodiazepin-5-one derivatives, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially of angiogenic disorders and hyperproliferative disorders in which neovascularization plays a role, for example ophthalmological disorders and cancers and tumours. Such treatments can be effected as monotherapy or else in combination with other medicaments or further therapeutic measures.
    Type: Grant
    Filed: November 23, 2015
    Date of Patent: August 14, 2018
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Andreas Schall, Jürgen Klar, Mario Lobell, Hartmut Schirok, Joachim Telser, Steffen Müller, Dirk Brohm, Hans Briem, Hannah Jörißen, Joerg Keldenich, Michael Böttger, Georges Von Degenfeld, Thomas Schlange, Ulf Bömer, Niels Lindner, Hanna Eilken, Dmitrij Hristodorov, Pierre Wasnaire, Kersten Matthias Gericke, Lars Bärfacker
  • Publication number: 20180208906
    Abstract: Described herein are RSV polynucleotide sequences that make use of multiple codons that are containing silent nucleotide substitutions engineered in multiple locations in the genome, wherein the substitutions introduce a numerous synonymous codons into the genome. Due to the large number of defects involved, the attenuated viruses disclosed herein provide a means of producing attenuated, live vaccines against RSV.
    Type: Application
    Filed: March 16, 2018
    Publication date: July 26, 2018
    Inventors: Peter L. Collins, Cyril Le Nouën, Linda G. Brock, Ursula J. Buchholz, Joshua Marc DiNapoli, Steffen Mueller, Eckard Wimmer
  • Patent number: 10023845
    Abstract: This invention provides an attenuated virus which comprises a modified viral genome containing nucleotide substitutions engineered in multiple locations in the genome, wherein the substitutions introduce synonymous deoptimized codons into the genome. The instant attenuated virus may be used in a vaccine composition for inducing a protective immune response in a subject. The invention also provides a method of synthesizing the instant attenuated virus. Further, this invention further provides a method for preventing a subject from becoming afflicted with a virus-associated disease comprising administering to the subject a prophylactically effective dose of a vaccine composition comprising the instant attenuated virus.
    Type: Grant
    Filed: September 7, 2016
    Date of Patent: July 17, 2018
    Assignee: The Research Foundation for The State University of New York
    Inventors: Eckard Wimmer, Steve Skiena, Steffen Mueller, Bruce Futcher, Dimitris Papamichail, John Robert Coleman, Jeronimo Cello
  • Patent number: 10024719
    Abstract: A measuring object for use in a heating apparatus for the thermal treatment of substrates is described, wherein the measuring object is the substrate to be treated or an object which in use has a substantially known temperature relation to the substrate to be treated, wherein the measuring object comprises a surface having at least one surface area, which acts as a measuring surface for an optical temperature measurement. A predetermined structure in the form of a plurality of recessions is formed in the surface area, in order to influence the emissivity of the surface area.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: July 17, 2018
    Assignee: CENTROTHERM PHOTOVOLTAICS AG
    Inventors: Dieter Zernickel, Steffen Mueller
  • Publication number: 20180143330
    Abstract: A radiometric detector is provided for detecting a measurement variable. The detector is particularly failsafe with, simultaneously, a simple, space-saving and cost-effective design, without having losses in the signal-to-noise ratio.
    Type: Application
    Filed: January 22, 2018
    Publication date: May 24, 2018
    Inventors: Dirk MOERMANN, Ewald FREIBURGER, Steffen MUELLER, Tobias DAIBENZEIHER
  • Publication number: 20180120454
    Abstract: A radiometric measuring device includes a scintillator, at least one semiconductor photodiode, wherein the at least one semiconductor photodiode is optically coupled to the scintillator, a signal evaluation unit which is electrically coupled to the at least one semiconductor photodiode and is designed to determine a measurement variable on the basis of a measurement signal produced by way of the at least one semiconductor photodiode, and an interface. The radiometric measuring device can be coupled to at least one receiver by way of the interface for the purpose of interchanging data. The radiometric measuring device is designed to be supplied with electrical energy solely via the interface thereof.
    Type: Application
    Filed: May 20, 2016
    Publication date: May 3, 2018
    Inventors: Steffen MUELLER, Ewald FREIBURGER, Tobias DAIBENZEIHER
  • Patent number: 9957486
    Abstract: Described herein are RSV polynucleotide sequences that make use of multiple codons that are containing silent nucleotide substitutions engineered in multiple locations in the genome, wherein the substitutions introduce a numerous synonymous codons into the genome. Due to the large number of defects involved, the attenuated viruses disclosed herein provide a means of producing attenuated, live vaccines against RSV.
    Type: Grant
    Filed: February 7, 2014
    Date of Patent: May 1, 2018
    Assignees: The United States of America, as represented by the Secretary, Dept. of Health and Human Services, The Research Foundation For the State University of New York
    Inventors: Peter L. Collins, Cyril Le Nouën, Linda G. Brock, Ursula J. Buchholz, Joshua Marc DiNapoli, Steffen Mueller, Eckard Wimmer
  • Patent number: 9897703
    Abstract: A radiometric detector is provided for detecting a measurement variable. The detector is particularly failsafe with, simultaneously, a simple, space-saving and cost-effective design, without having losses in the signal-to-noise ratio.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: February 20, 2018
    Assignee: Berthold Technologies GmbH & Co. KG
    Inventors: Dirk Moermann, Ewald Freiburger, Steffen Mueller, Tobias Daibenzeiher
  • Patent number: 9851301
    Abstract: A method for automated identification of a state of a sample such as, for example, for identifying whether or not the sample was centrifuged is presented. A device for analyzing samples and a laboratory automation system are also presented in which the method is applied.
    Type: Grant
    Filed: March 25, 2016
    Date of Patent: December 26, 2017
    Assignee: Roche Diagnostics Operations, Inc.
    Inventor: Steffen Mueller
  • Publication number: 20170253602
    Abstract: The present application relates to novel (3-hydroxyphenyl)amino-substituted pyrido[2,3-b][1,5]benzodiazepin-5-one derivatives, to processes for preparation thereof, to the use thereof alone or in combination for treatment and/or prevention of diseases and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially of angiogenic disorders and hyperproliferative disorders in which neovascularization plays a role, for example ophthalmological disorders and cancers and tumours. Such treatments can be effected as monotherapy or else in combination with other medicaments or further therapeutic measures.
    Type: Application
    Filed: November 23, 2015
    Publication date: September 7, 2017
    Applicant: Bayer Pharma Aktiengesellschaft
    Inventors: Andreas SCHALL, Jürgen KLAR, Mario LOBELL, Hartmut SCHIROK, Joachim TELSER, Steffen MÜLLER, Dirk BROHM, Hans BRIEM, Hannah JÖRIßEN, Joerg KELDENICH (deceased), Michael BÖTTGER, Georges DEGENFELD VON, Thomas SCHLANGE, Ulf BÖMER, Niels LINDNER, Hanna EILKEN, Dmitrij HRISTODOROV, Pierre WASNAIRE, Kersten Matthias GERICKE, Lars BÄRFACKER
  • Patent number: 9730674
    Abstract: An example system includes a probe to generate ultrasound scans; a user interface to receive inputs from and to provide outputs to a user; and a controller to receive selection of an objective value for each of a plurality of lung sectors of a patient and present an objective lung assessment to the user through the user interface.
    Type: Grant
    Filed: March 31, 2015
    Date of Patent: August 15, 2017
    Assignee: General Electric Company
    Inventors: Frank-Steffen Mueller, Alexander Sokulin, Peter Lysyansky
  • Publication number: 20170067030
    Abstract: This invention provides an attenuated virus which comprises a modified viral genome containing nucleotide substitutions engineered in multiple locations in the genome, wherein the substitutions introduce synonymous deoptimized codons into the genome. The instant attenuated virus may be used in a vaccine composition for inducing a protective immune response in a subject. The invention also provides a method of synthesizing the instant attenuated virus. Further, this invention further provides a method for preventing a subject from becoming afflicted with a virus-associated disease comprising administering to the subject a prophylactically effective dose of a vaccine composition comprising the instant attenuated virus.
    Type: Application
    Filed: September 7, 2016
    Publication date: March 9, 2017
    Inventors: Eckard Wimmer, Steve Skiena, Steffen Mueller, Bruce Futcher, Dimitris Papamichail, John Robert Coleman, Jeronimo Cello
  • Patent number: 9476032
    Abstract: This invention provides an attenuated virus which comprises a modified viral genome containing nucleotide substitutions engineered in multiple locations in the genome, wherein the substitutions introduce synonymous deoptimized codons into the genome. The instant attenuated virus may be used in a vaccine composition for inducing a protective immune response in a subject. The invention also provides a method of synthesizing the instant attenuated virus. Further, this invention further provides a method for preventing a subject from becoming afflicted with a virus-associated disease comprising administering to the subject a prophylactically effective dose of a vaccine composition comprising the instant attenuated virus.
    Type: Grant
    Filed: March 31, 2008
    Date of Patent: October 25, 2016
    Assignee: The Research Foundation for The State University of New York
    Inventors: Eckard Wimmer, Steve Skiena, Steffen Mueller, Bruce Futcher, Dimitris Papamichail, John Robert Coleman, Jeronimo Cello
  • Publication number: 20160287217
    Abstract: An example system includes a probe to generate ultrasound scans; a user interface to receive inputs from and to provide outputs to a user; and a controller to receive selection of an objective value for each of a plurality of lung sectors of a patient and present an objective lung assessment to the user through the user interface.
    Type: Application
    Filed: March 31, 2015
    Publication date: October 6, 2016
    Inventors: Frank-Steffen Mueller, Alexander Sokulin, Peter Lysyansky
  • Publication number: 20160259066
    Abstract: A radiometric detector is provided for detecting a measurement variable. The detector is particularly failsafe with, simultaneously, a simple, space-saving and cost-effective design, without having losses in the signal-to-noise ratio.
    Type: Application
    Filed: March 4, 2016
    Publication date: September 8, 2016
    Inventors: Dirk MOERMANN, Ewald FREIBURGER, Steffen MUELLER, Tobias DAIBENZEIHER
  • Patent number: D788267
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: May 30, 2017
    Assignee: Robert Bosch GmbH
    Inventors: Steffen Mueller, Jichao Zhu, Jonas Vollmer